Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?

Area of Science:

• Immunology
• Cardiology
• Virology

Background:

• Viral myocarditis (VMC) is a significant cause of heart failure and dilated cardiomyopathy.
• Coxsackievirus B3 (CVB3) is a common viral agent associated with VMC.
• Current diagnostic and treatment options for VMC are limited.

Purpose of the Study:

• To review recent advances in understanding the immune response to CVB3 infection.
• To explore the role of innate and adaptive immunity in the pathogenesis of VMC.
• To investigate the potential involvement of the intestine and its microflora in VMC.

Main Methods:

• Review of current literature on CVB3-induced myocarditis.
• Analysis of host immune responses, including Th1, Th17, and macrophage involvement.
• Examination of innate immune pathways (TLR3, TLR4, TLR8, MDA5) in CVB3 infection.
• Consideration of the intestine as an initial infection site and its immune interactions.

Main Results:

• Acute myocarditis is primarily mediated by host immune responses like Th1, Th17, and type I macrophages.
• Innate immunity, triggered by specific Toll-like receptors (TLRs) and MDA5, contributes to inflammatory cytokine induction.
• The intestine's role in CVB3 replication and subsequent immune modulation requires further investigation.
• Interactions between innate immunity and gut microflora may influence VMC pathogenesis.

Conclusions:

• A comprehensive understanding of both innate and adaptive immunity is crucial for VMC.
• Investigating the gut-heart axis offers potential new therapeutic targets for VMC.
• Further research into immune mechanisms can lead to improved VMC treatment strategies.